AU2003257814A1 - Medicinal composition for lowering blood lipid level - Google Patents

Medicinal composition for lowering blood lipid level

Info

Publication number: AU2003257814A1
Authority: AU; Australia
Prior art keywords: medicinal composition; blood lipid; lowering blood; lipid level; level
Prior art date: 2002-08-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003257814A

Inventor

Tatsuhito Kondo

Masato Nakayama

Ikuo Takagi

Yasuhiro Torizumi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sankyo Co Ltd

Original Assignee

Sankyo Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-08

Filing date

2003-08-06

Publication date

2004-02-25

2003-08-06 Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd

2004-02-25 Publication of AU2003257814A1 publication Critical patent/AU2003257814A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2003257814A 2002-08-08 2003-08-06 Medicinal composition for lowering blood lipid level Abandoned AU2003257814A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2002/231618		2002-08-08
JP2002231618		2002-08-08
PCT/JP2003/010028 WO2004014427A1 (en)	2002-08-08	2003-08-06	Medicinal composition for lowering blood lipid level

Publications (1)

Publication Number	Publication Date
AU2003257814A1 true AU2003257814A1 (en)	2004-02-25

Family

ID=31711752

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003257814A Abandoned AU2003257814A1 (en)	2002-08-08	2003-08-06	Medicinal composition for lowering blood lipid level

Country Status (5)

Country	Link
CN (1)	CN1688341A (en)
AU (1)	AU2003257814A1 (en)
CA (1)	CA2494916A1 (en)
TW (1)	TW200404533A (en)
WO (1)	WO2004014427A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3654955A1 (en) *	2017-07-17	2020-05-27	Eli Lilly and Company	Pharmaceutical compositions
CN109248152B (en) *	2018-11-02	2021-01-12	河北医科大学第二医院	A pharmaceutical preparation for treating liver and gallbladder diseases, and its preparation method
CN118085002A (en) *	2020-04-28	2024-05-28	华东师范大学	Process for preparing cholic acid derivatives

2003
- 2003-08-06 CN CNA038239841A patent/CN1688341A/en active Pending
- 2003-08-06 WO PCT/JP2003/010028 patent/WO2004014427A1/en not_active Application Discontinuation
- 2003-08-06 CA CA002494916A patent/CA2494916A1/en not_active Abandoned
- 2003-08-06 AU AU2003257814A patent/AU2003257814A1/en not_active Abandoned
- 2003-08-07 TW TW092121592A patent/TW200404533A/en unknown

Also Published As

Publication number	Publication date
CN1688341A (en)	2005-10-26
WO2004014427A1 (en)	2004-02-19
CA2494916A1 (en)	2004-02-19
TW200404533A (en)	2004-04-01

Similar Documents

Publication	Publication Date	Title
EP2295053B8 (en)	2018-03-28	Novel 2H-chromen-2-one-3-carboxamides for medical uses
AU2003211376A1 (en)	2003-09-09	Drug administration method
AU2003278393A1 (en)	2004-06-07	New use for pharmaceutical composition
AU2003254553A1 (en)	2004-02-09	Medical implant
AU2003253106A1 (en)	2004-01-23	Medical implant
AU2003291103A1 (en)	2004-06-15	Pharmaceutical composition
AU2003232258A1 (en)	2003-12-12	Medical implant
AU2003250372A1 (en)	2004-01-06	Pharmaceutical composition
AU2003220956A1 (en)	2003-10-20	Insulin administration apparatus
HK1077232A1 (en)	2006-02-10	Medicinal composition for mitigating blood lipid or lowering blood homocystein
AU2003300995A1 (en)	2004-07-22	Patient support surface
AU2002221131A1 (en)	2002-06-24	Blood lipid ameliorant composition
AU2003225244A1 (en)	2003-11-11	Pharmaceutical compositions for lowering blood glucose and blood cholesterol levels
AU2003250317A1 (en)	2004-02-25	Device for administration of fluids
AU2003244082A1 (en)	2004-01-19	Drug composition for blood sugar control
AU2003284460A1 (en)	2004-06-23	Medicinal composition
AU2003271204A1 (en)	2004-05-04	Composition for lowering blood glucose level comprising extract of natural product
AU2003291642A1 (en)	2004-06-18	Pyrazoloazepine compounds as pharmaceutical agents
AU2003257814A1 (en)	2004-02-25	Medicinal composition for lowering blood lipid level
AU2003302320A1 (en)	2004-06-23	Seterocyclic quinones as pharmaceutical agents
AU2003280799A1 (en)	2004-06-15	Medicinal composition
AU2003224026A1 (en)	2003-10-13	Patient support structures
AU2003235931A1 (en)	2003-11-11	Vintoperol-containing medicinal composition for transdermal administration
AU2003227475A1 (en)	2003-10-20	Drug containing riboflavin compound
AU2003280678A1 (en)	2004-05-25	Medicinal composition

Legal Events

Date	Code	Title	Description
2005-05-19	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase